Literature DB >> 22003107

Central areolar choroidal dystrophy (CACD) and age-related macular degeneration (AMD): differentiating characteristics in multimodal imaging.

Dženita Smailhodzic1, Monika Fleckenstein, Thomas Theelen, Camiel J F Boon, Ramon A C van Huet, Johannes P H van de Ven, Anneke I Den Hollander, Steffen Schmitz-Valckenberg, Carel B Hoyng, Bernhard H F Weber, Frank G Holz, B Jeroen Klevering.   

Abstract

PURPOSE: Late-onset central areolar choroidal dystrophy (CACD) may easily be confused with geographic atrophy (GA) in AMD. To detect discerning features, the morphologic changes in CACD patients and in AMD patients were assessed with confocal scanning laser ophthalmoscopy (cSLO), fundus autofluorescence (FAF), and spectral-domain optical coherence tomography (SD-OCT).
METHODS: A total of 30 CACD patients with identified PRPH2 gene mutations were analyzed and compared to 19 patients with early AMD and 13 patients with AMD-associated GA. The presence of drusen and pigment clumping was determined with color fundus photography. High-resolution in vivo imaging was performed with cSLO and SD-OCT. FAF images and SD-OCT volume scans were analyzed in each study eye.
RESULTS: On FAF, a speckled FAF pattern occurred significantly more often in CACD (85%) than in early AMD (5.6%; P < 0.0001). There was a significantly higher frequency of sub-RPE deposits in eyes with AMD than in eyes with CACD (36.8% versus 2.1% of scans, P = 0.0019). Reticular drusen could be visualized by SD-OCT and FAF imaging in 52.6% of the eyes with early AMD and in 100% of the eyes with GA, whereas this drusen phenotype did not manifest in eyes with CACD.
CONCLUSIONS: Although outer retinal atrophy is the clinically common feature in advanced CACD as well as GA, there are microstructural alterations on high-resolution SD-OCT and FAF imaging that allow for the differentiation between CACD and AMD. The findings may help to identify patients in whom a diagnostic PRPH2 screening is warranted. (ClinicalTrials.gov number, NCT00393692.).

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22003107     DOI: 10.1167/iovs.11-7926

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  19 in total

Review 1.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 2.  Recent developments in the treatment of age-related macular degeneration.

Authors:  Frank G Holz; Steffen Schmitz-Valckenberg; Monika Fleckenstein
Journal:  J Clin Invest       Date:  2014-04-01       Impact factor: 14.808

Review 3.  GEOGRAPHIC ATROPHY: Semantic Considerations and Literature Review.

Authors:  Steffen Schmitz-Valckenberg; Srinivas Sadda; Giovanni Staurenghi; Emily Y Chew; Monika Fleckenstein; Frank G Holz
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

4.  Prevalence of Subretinal Drusenoid Deposits in Older Persons with and without Age-Related Macular Degeneration, by Multimodal Imaging.

Authors:  Anna V Zarubina; David C Neely; Mark E Clark; Carrie E Huisingh; Brian C Samuels; Yuhua Zhang; Gerald McGwin; Cynthia Owsley; Christine A Curcio
Journal:  Ophthalmology       Date:  2016-02-10       Impact factor: 12.079

Review 5.  A Review of Secondary Photoreceptor Degenerations in Systemic Disease.

Authors:  Naveen Mysore; Jamie Koenekoop; Shen Li; Huanan Ren; Vafa Keser; Irma Lopez-Solache; Robert K Koenekoop
Journal:  Cold Spring Harb Perspect Med       Date:  2014-12-04       Impact factor: 6.915

6.  Gold Nanorod Enhanced Photoacoustic Microscopy and Optical Coherence Tomography of Choroidal Neovascularization.

Authors:  Van-Phuc Nguyen; Yanxiu Li; Jessica Henry; Wei Zhang; Xueding Wang; Yannis M Paulus
Journal:  ACS Appl Mater Interfaces       Date:  2021-08-17       Impact factor: 10.383

7.  PRPH2 mutation update: In silico assessment of 245 reported and 7 novel variants in patients with retinal disease.

Authors:  Manon H C A Peeters; Mubeen Khan; Anoek A M B Rooijakkers; Timo Mulders; Lonneke Haer-Wigman; Camiel J F Boon; Caroline C W Klaver; L Ingeborgh van den Born; Carel B Hoyng; Frans P M Cremers; Anneke I den Hollander; Claire-Marie Dhaenens; Rob W J Collin
Journal:  Hum Mutat       Date:  2021-09-20       Impact factor: 4.700

8.  Subretinal drusenoid deposits in non-neovascular age-related macular degeneration: morphology, prevalence, topography, and biogenesis model.

Authors:  Christine A Curcio; Jeffrey D Messinger; Kenneth R Sloan; Gerald McGwin; Nancy E Medeiros; Richard F Spaide
Journal:  Retina       Date:  2013-02       Impact factor: 4.256

9.  Phenotypic Differences in a PRPH2 Mutation in Members of the Same Family Assessed with OCT and OCTA.

Authors:  Henar Albertos-Arranz; Xavier Sánchez-Sáez; Natalia Martínez-Gil; Isabel Pinilla; Rosa M Coco-Martin; Jesús Delgado; Nicolás Cuenca
Journal:  Diagnostics (Basel)       Date:  2021-04-26

10.  Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.

Authors:  Felix Grassmann; Monika Fleckenstein; Emily Y Chew; Tobias Strunz; Steffen Schmitz-Valckenberg; Arno P Göbel; Michael L Klein; Rinki Ratnapriya; Anand Swaroop; Frank G Holz; Bernhard H F Weber
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.